Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12446095 | 0.95 | ALDH1A1 (0.33) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL20851353 | 0.88 | — | — | |
| SCHEMBL26667076 | 0.88 | MAPK1 (0.31) | MAPK1 | |
| SCHEMBL13455172 | 0.87 | — | — | |
| SCHEMBL12559718 | 0.87 | TSHR (0.35) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL19072534 | 0.87 | MEN1 (0.46) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL13183444 | 0.86 | — | — | |
| SCHEMBL12146535 | 0.86 | TSHR (0.30) | TSHR | |
| SCHEMBL22355287 | 0.86 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL12819577 | 0.86 | CYP4F2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11583569-B2 | PSMA-targeting amanitin conjugates | HEIDELBERG PHARMA RESEARCH GMBH (DE) | 2023-02-21 | — | — | US | disclosed |
| EP-3601206-B1 | PROCESS FOR PREPARING AN ANTICORROSION COMPONENT FOR AN ANTIFREEZE | BASF SE (DE) | 2021-07-21 | — | — | EP | disclosed |
| US-11066391-B1 | Atorvastatin derived HMG-CoA reductase degradation inducing compound | UPPTHERA (KR) | 2021-07-20 | — | — | US | disclosed |
| US-20210155746-A1 | HYBRID ANIONIC, NONIONIC WATER-BASED POLYURETHANE-POLYUREA | U.S. POLYMERS-ACCUREZ, LLC | 2021-05-27 | — | — | US | disclosed |
| US-10961177-B2 | Process for preparing an anticorrosion component for an antifreeze | BASF SE | 2021-03-30 | — | — | US | disclosed |
| US-20200345807-A1 | PSMA-TARGETING AMANITIN CONJUGATES | HEIDELBERG PHARMA RESEARCH GMBH (DE) | 2020-11-05 | — | — | US | disclosed |
| US-20200283365-A1 | PROCESS FOR PREPARING AN ANTICORROSION COMPONENT FOR AN ANTIFREEZE | BASF SE (DE) | 2020-09-10 | — | — | US | disclosed |
| EP-2872496-B1 | POLYGLYCOL BIS-[3-(7-TERT-BUTYL-2-OXO-3-PHENYL-3H-BENZOFURAN-5-YL-)PROPANOYL]DERIVATIVES AS STABILIZERS OF ORGANIC MATERIAL | BASF SE (DE) | 2018-02-28 | — | — | EP | disclosed |
| WO-2016050210-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | 厦门赛诺邦格生物科技有限公司 | 2016-04-07 | — | — | WO | disclosed |
| US-20110142941-A1 | Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof | NANOPHARMACEUTICALS LLC | 2011-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11066391-B1 | Atorvastatin derived HMG-CoA reductase degradation inducing compound | HMGCR, LDLR, HMGB2 | ALDH1A1 1806/4885TSHR 4230/4885MAPK1 3926/4885 |
| US-20200345807-A1 | PSMA-TARGETING AMANITIN CONJUGATES | FOLH1, ANPEP, PSMA6 | ALDH1A1 2847/4885TSHR 2131/4885MAPK1 4107/4885 |
| US-20200283365-A1 | PROCESS FOR PREPARING AN ANTICORROSION COMPONENT FOR AN ANTIFREEZE | POLA1, SERPINC1, POLD1 | ALDH1A1 2366/4885TSHR 4121/4885MAPK1 1095/4885 |
| US-20110142941-A1 | Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof | TSHR, THRA, TRHR | ALDH1A1 3675/4885TSHR 1/4885MAPK1 2321/4885 |
| US-11583569-B2 | PSMA-targeting amanitin conjugates | FOLH1, ANPEP, PSMA6 | ALDH1A1 2847/4885TSHR 2131/4885MAPK1 4107/4885 |
| US-10961177-B2 | Process for preparing an anticorrosion component for an antifreeze | POLA1, SCO2, OGDH | ALDH1A1 867/4885TSHR 3588/4885MAPK1 798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.